Cargando…

A radiomics model predicts the response of patients with advanced gastric cancer to PD-1 inhibitor treatment

Programmed cell death 1 (PD1) inhibitors have shown promising treatment effects in advanced gastric cancer, the beneficiary population not definite. This study aimed to construct an individualized radiomics model to predict the treatment benefits of PD-1 inhibitors in gastric cancer. Patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Zhiwen, Huang, Ai, Wang, Linfang, Bi, Jianping, Kuang, Bohua, Xiao, Yong, Yu, Dandan, Hong, Ma, Zhang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833127/ https://www.ncbi.nlm.nih.gov/pubmed/35073519 http://dx.doi.org/10.18632/aging.203850

Ejemplares similares

Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC
por: Bouhamama, Amine, et al.
Publicado: (2023)

Progress in Radiotherapy for Cholangiocarcinoma
por: Wang, Ningyu, et al.
Publicado: (2022)

Utility of CT radiomics for prediction of PD‐L1 expression in advanced lung adenocarcinomas
por: Yoon, Jiyoung, et al.
Publicado: (2020)

Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2023)

Preoperative prediction of vessel invasion in locally advanced gastric cancer based on computed tomography radiomics and machine learning
por: Hu, Zhi-Wei, et al.
Publicado: (2023)

A radiomics-based model for predicting prognosis of locally advanced gastric cancer in the preoperative setting
por: Shin, Jaeseung, et al.
Publicado: (2021)

Are radiomic spleen features useful for assessing the differentiation status of advanced gastric cancer?
por: Lyu, Dongbo, et al.
Publicado: (2023)

PD-1 Inhibitors in the Advanced Esophageal Cancer
por: Hong, Ye, et al.
Publicado: (2019)

Application of radiomics in predicting the preoperative risk stratification of gastric stromal tumors
por: Yang, Li, et al.
Publicado: (2022)

Advanced gastric cancer: CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy
por: Xu, Qinmei, et al.
Publicado: (2021)

Predicting Chemotherapeutic Response for Far-advanced Gastric Cancer by Radiomics with Deep Learning Semi-automatic Segmentation
por: Tan, Jing-wen, et al.
Publicado: (2020)

Association between radiomics features of DCE-MRI and CD8(+) and CD4(+) TILs in advanced gastric cancer
por: Huang, Huizhen, et al.
Publicado: (2023)

A PD-L1 Negative Advanced Gastric Cancer Patient With a Long Response to PD-1 Blockade After Failure of Systematic Treatment: A Case Report
por: Zhang, Fangyuan, et al.
Publicado: (2021)

CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Yong, et al.
Publicado: (2022)

Case report: Significant response to PD-L1 inhibitor after resistance to PD-1 inhibitor in an advanced alpha-fetoprotein-positive gastric cancer
por: Wang, Liyu, et al.
Publicado: (2022)

Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma
por: Tao, Yun-Yun, et al.
Publicado: (2023)

The lymphocyte-to-monocyte ratio could predict the efficacy of PD-1 inhibitors in patients with advanced cancer
por: Xiao, Li, et al.
Publicado: (2020)

Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study
por: Xu, Bin, et al.
Publicado: (2022)

Impact of low serum iron on treatment outcome of PD-1 inhibitors in advanced gastric cancer
por: Yang, Yu, et al.
Publicado: (2023)

Radiomics in esophageal and gastric cancer
por: Sah, Bert-Ram, et al.
Publicado: (2019)

A Transfer Learning Radiomics Nomogram for Preoperative Prediction of Borrmann Type IV Gastric Cancer From Primary Gastric Lymphoma
por: Feng, Bao, et al.
Publicado: (2022)

Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer
por: Wei, Xiao-Li, et al.
Publicado: (2021)

Advancements of molecular imaging and radiomics in pancreatic carcinoma
por: Pang, Xiao-Xi, et al.
Publicado: (2023)

Clinical-radiomic model in advanced kidney cancer predicts response to tyrosine kinase inhibitors
por: Negreros-Osuna, Adrián A., et al.
Publicado: (2022)

Advances in CT features and radiomics of checkpoint inhibitor-related pneumonitis: A short review
por: Huang, Jie, et al.
Publicado: (2023)

Evaluation of Epidermal Growth Factor Receptor 2 Status in Gastric Cancer by CT-Based Deep Learning Radiomics Nomogram
por: Guan, Xiao, et al.
Publicado: (2022)

Radiomics Nomogram for Prediction of Peritoneal Metastasis in Patients With Gastric Cancer
por: Huang, Weicai, et al.
Publicado: (2020)

A CT-based radiomics signature for prediction of HER2 overexpression and treatment efficacy of trastuzumab in advanced gastric cancer
por: Ma, Tingting, et al.
Publicado: (2022)

Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients
por: Farina, Benito, et al.
Publicado: (2023)

CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors
por: Li, Jiazheng, et al.
Publicado: (2023)

(18)F-FDG PET/CT-based radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer
por: Xue, Xiu-qing, et al.
Publicado: (2022)

Machine Learning: Applications and Advanced Progresses of Radiomics in Endocrine Neoplasms
por: Wang, Yong, et al.
Publicado: (2021)

PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study
por: Wei, Qing, et al.
Publicado: (2020)

PD-1 inhibitors-based second-line therapy for metastatic gastric cancer
por: Gou, Miaomiao, et al.
Publicado: (2023)

Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis
por: Yuan, Zhen, et al.
Publicado: (2023)

Development and Validation of a Computed Tomography–Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Wei, et al.
Publicado: (2021)

Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer
por: Wang, Xiao-Xiao, et al.
Publicado: (2020)

Predicting Response to Systemic Chemotherapy for Advanced Gastric Cancer Using Pre-Treatment Dual-Energy CT Radiomics: A Pilot Study
por: Liu, Yi-yang, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer
por: Gou, Miaomiao, et al.
Publicado: (2021)

The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
por: Chen, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_698aa7buqh87bl8p384rdf69o7